Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Charmacy Pharmaceutical Co., Ltd. Class H ( (HK:2289) ) is now available.
Charmacy Pharmaceutical Co., Ltd. has announced an extraordinary general meeting (EGM) scheduled for December 12, 2025, to discuss several key resolutions. These include a new framework loan agreement with Jiangyao Group Co., Ltd., the appointment of Pan-China Certified Public Accountants LLP as auditors, and proposed amendments to the company’s articles of association. These resolutions, if approved, could impact the company’s financial arrangements and governance structure, potentially influencing its market positioning and operational efficiency.
More about Charmacy Pharmaceutical Co., Ltd. Class H
Charmacy Pharmaceutical Co., Ltd. is a pharmaceutical company based in the People’s Republic of China, focusing on the pharmaceutical industry. It is involved in the development, production, and distribution of pharmaceutical products.
Average Trading Volume: 2,653
Technical Sentiment Signal: Buy
Current Market Cap: HK$799.2M
See more data about 2289 stock on TipRanks’ Stock Analysis page.